These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4871164)

  • 21. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis.
    Meyer KF; Hightower JA; McCrumb FR
    J Infect Dis; 1974 May; 129():Suppl:S41-5. PubMed ID: 4825248
    [No Abstract]   [Full Text] [Related]  

  • 22. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.
    Bubeck SS; Dube PH
    Clin Vaccine Immunol; 2007 Sep; 14(9):1235-8. PubMed ID: 17652523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary characterization of the properties and diagnostic value of the antigenic complex "fraction V" in a plague microbe].
    Bozhko NV; Lebedeva SA; Bichul' OK; Ivanova VS; Lysova LK; Barabash GP; Nekliaev VN; trukhachev AL; Terent'ev AN
    Klin Lab Diagn; 2005 Jun; (6):45-9. PubMed ID: 16078534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The possibility of preserving the causative agent of plague in soil in resting (nonculturable) form].
    Suchkov IuG; Khudiakov IV; Emel'ianenko EN; Levi MI; Pushkareva VI; Suchko IIu; Litvin VIu; Kulesh EV; Zotova RS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (4):42-6. PubMed ID: 9340999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of plague vaccines in mice and guinea pigs.
    von Metz E; Eisler DM; Hottle GA
    Appl Microbiol; 1971 Jul; 22(1):84-8. PubMed ID: 5111306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BIOLOGICAL ACTIVITIES IN EXTRACTS OF PASTEURELLA PESTIS AND THEIR RELATION TO THE "PH 6 ANTIGEN".
    BICHOWSKY-SLOMNICKI L; BEN-EFRAIM S
    J Bacteriol; 1963 Jul; 86(1):101-11. PubMed ID: 14051801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid detection of Yersinia pestis recombinant fraction 1 capsular antigen.
    Tsui PY; Tsai HP; Chiao DJ; Liu CC; Shyu RH
    Appl Microbiol Biotechnol; 2015 Sep; 99(18):7781-9. PubMed ID: 25994256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence of persistent Yersina pestis infection at prairie dog colonies in north-central Montana.
    Holmes BE; Foresman KR; Matchett MR
    J Wildl Dis; 2006 Jan; 42(1):164-9. PubMed ID: 16699160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [IMMUNITY IN PLAGUE. ACQUISITIONS SUPPLIED BY 30 YEARS OF WORK ON THE "PASTEURELLA PESTIS EV" (GIRARD AND ROBIC) STRAIN].
    GIRARD G
    Biol Med (Paris); 1963; 52():631-731. PubMed ID: 14095162
    [No Abstract]   [Full Text] [Related]  

  • 30. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between staphylococcal antiserum titer and zone development on immune serum plates.
    Weiss KF; Robbins RN
    Appl Microbiol; 1970 Jun; 19(6):911-4. PubMed ID: 4917190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [STUDY OF THE VIRULENCE OF PASTEURELLA PESTIS AND PREPARATION OF LIVE VACCINES AGAINST PLAGUE. 3. CHEMICAL STRUCTURE OF PASTEURELLA PESTIS WITH DIFFERENT VIRULENCE].
    MALININA ZE; EGOROVA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Oct; 41():98-102. PubMed ID: 14295829
    [No Abstract]   [Full Text] [Related]  

  • 33. PLAGUE.
    BURKE-GAFFNEY HJ
    Trop Dis Bull; 1964 Jul; 61():633-9. PubMed ID: 14153184
    [No Abstract]   [Full Text] [Related]  

  • 34. [ANTIALDOLASE ACTIVITY OF THE ANTIPLAGUE SERUM AND DIFFERENCE IN ALDOLASE ISOLATED FROM P. PESTIS AND ITS TOXIN].
    DOMARADSKII IV; KLIMOVA IM
    Biull Eksp Biol Med; 1964 Apr; 13():84-7. PubMed ID: 14248429
    [No Abstract]   [Full Text] [Related]  

  • 35. Yersinia pestis: correlation of ultrastructures and immunological status.
    Chen TH; Elberg SS; Boyles J; Velez MA
    Infect Immun; 1975 Jun; 11(6):1382-90. PubMed ID: 1095487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The results of a 15-year study of the persistence of Yersinia pestis L-forms].
    Zykin LF
    Zh Mikrobiol Epidemiol Immunobiol; 1994; Suppl 1():68-71. PubMed ID: 7856355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness of revaccinating hamadryas baboons with NISS live dried plague vaccine and fraction I of the plague microbe].
    Byvalov AA; Pautov VN; Chicherin IuV; Lebedinskiĭ VA; Evtigneev VI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):74-6. PubMed ID: 6741359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Latex agglutination tests for measurement of antiplague antibodies.
    Suzuki S; Sakakibara H; Hotta S
    J Clin Microbiol; 1977 Oct; 6(4):332-6. PubMed ID: 914990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kinetics of the immunologic agglutination reaction and express determination of bacteria using an automated laser photon-correlation spectrometer].
    Ersh IG; Muratov LS; Novozhilov SIu; Shtokman BM; Shtokman MI
    Dokl Akad Nauk SSSR; 1986; 287(5):1239-44. PubMed ID: 3516614
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.
    Thomas RE; Simpson WJ; Perry LL; Schwan TG
    Am J Trop Med Hyg; 1992 Jul; 47(1):92-7. PubMed ID: 1386197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.